Impaired monocyte cytokine production in critically ill patients with acute renal failure

Kidney International

Volumn 66, Issue 6, 2004, Pages 2354-2360

  Himmelfarb, Jonathan ^a   Le, Phuong ^b   Klenzak, Jennifer ^b   Freedman, Stephanie ^b   McMenamin, M Elizabeth ^b   Ikizler, T Alp ^b  

^a MAINE MEDICAL CENTER   (United States)

^b NONE

Author keywords

Acute renal failure; Cytokine; Inflammation; Monocyte; PICARD

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; INTERLEUKIN 1;

ACUTE KIDNEY FAILURE; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; CRITICAL ILLNESS; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; MONOCYTE; PRIORITY JOURNAL; AGED; BLOOD; CHRONIC KIDNEY FAILURE; FEMALE; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED;

AGED; CRITICAL ILLNESS; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; KIDNEY FAILURE, ACUTE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MONOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 21644454823     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.66023.x     Document Type: Article

References (57)

1. THADHANI R, PASCUAL M, BONVENTRE JV: Acute renal failure. N Engl J Med 334:1448-1460, 1996
2. LIANO F, PASCUAL J: Outcomes in acute renal failure. Semin Nephrol 18:541-550, 1998
3. STAR RA: Treatment of acute renal failure. Kidney Int 54:1817-1831, 1998
4. LIANO F, JUNCO E, PASCUAL J, et al: The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings. The Madrid Acute Renal Failure Study Group. Kidney Int (Suppl 66):S16-S24, 1998
5. MEHTA RL, MCDONALD B, GABBAI FB, et al: A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int 60:1154-1163, 2001
6. NASH K, HAFEEZ A, HOU S: Hospital-acquired renal insufficiency. Am J Kidney Dis 39:930-936, 2002
7. SCHIFFL H, LANG SM, FISCHER R: Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 346:305-310, 2002
8. ACKER CG, SINGH AR, FLICK RP, et al: A trial of thyroxine in acute renal failure. Kidney Int 57:293-298, 2000
9. WANG A, HOLCSLAW T, BASHORE TM, et al: Exacerbation of radio-contrast nephrotoxicity by endothelin receptor antagonism. Kidney Int 57:1675-1680, 2000
10. SIMMONS EM, HIMMELFARB J, SEZER MT, et al: Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney Int 65:1357-1365, 2004
11. ALLISON AC, LEE JC, EUGUI EM: Pharmacological regulation of the production of inflammatory cytokines TNF-α and IL-1-β, in Human Cytokines: Their Role in Disease and Therapy, edited by Aggarwal B, Puri RK, Boston, Blackwell Science, 1995, pp 689-713
12. MAINO VC, PICKER LJ: Identification of functional subsets by flow cytometry: Intracellular detection of cytokine expression. Cytometry 34:207-215, 1998
13. BIENVENU J, MONNERET G, FABIEN N, REVILLARD JP: The clinical usefulness of the measurement of cytokines. Clin Chem Lab Med 38:267-285, 2000
14. DELARCHE C, CHOLLET-MARTIN S: Plasma cytokines: What we are measuring. Current Opinion in Clinical Nutrition and Metabolic Care 2:475-479, 1999
15. PUGIN J, RICOU B, STEINBERG KP, et al: Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1. Am Respir Care Med 153:1850-1856, 1996
16. GRENIER A, DEHOUX M, BOUTTEN A, et al: Oncostatin M production and regulation by human polymorphonuclear neutrophils. Blood 93:1413-1421, 1999
17. CHOLLET-MARTIN S, MONTRAVERS P, GILBERT C, et al: High levels of interleukin-8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome. Infect Immun 61:4553-4559, 1993
18. MEDURI GU, KOHLER G, HEADLEY S, et al: Inflammatory cytokines in the BAL of patients with ARDS. Chest 108:1303-1314, 1995
19. DONNELLY SC, STREITER RM, REID PT, et al: The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome. Ann Intern Med 125:191-196, 1996
20. PITTET JF, MACKERSIE RC, MARTIN TR, et al: Biological markers of acute lung injury: Prognostic and pathogenetic significance. Am J Respir Crit Care Med 155:1187-1205, 1997
21. OTTO G, BRACONIER JA, ANDREASSON A, SVANBORG C: Interleukin-6 and disease severity in patients with bacteremic and nonbacteremic febrile urinary tract infection. J Intern Med 179:172-179, 1999
22. ERTEL W, KREMER JP, KENNEY J, et al: Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood 85:1341-1347, 1995
23. GOGOS CA, DROSOU E, BASSARIS HP, SKOUTELIS A: Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: A marker for prognosis and future therapeutic options. J Infect Dis 181:176-180, 2000
24. VAN DISSEL JT, VAN LANGEVELDE P, WESTENDORP RG, et al: Antiinflammatory cytokine profile and mortality in febrile patients. Lancet 351:950-953, 1998
25. ASTIZ M, SAHA D, LUSTBADER D, et al: Monocyte response to bacterial toxins, expression of cell surface receptors, and release of antiinflammatory cytokines during sepsis. J Lab Clin Med 128:594-600, 1996
26. MUNOZ C, CARLET J, FITTING C, et al: Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 88:1747-1754, 1991
27. CHERTOW GM, PASCUAL MT, SOROKO S, et al: Reasons for non-enrollment in a cohort study of ARF: The Program to Improve Care in Acute Renal Disease (PICARD) experience and implications for a clinical trials network. Am J Kidney Dis 42:507-512, 2003
28. LE GALL JR, LEMESHOW S, SAULNIER F: A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957-2963, 1993
29. VINCENT JL, MORENO R, TAKALA J, et al: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707-710, 1996
30. BONE RC, BALK RA, CERRA FB, et al: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644-1655, 1992
31. SCHINDLER R, GELFAND JA, DINARELLO CA: Recombinant C5a stimulates transcription rather than translation of interleukin-1 (IL-1) and tumor necrosis factor: Translational signal provided by lipopolysaccharide or IL-1 itself. Blood 76:1631-1638, 1990
32. SCHINDLER R, LONNEMANN G, SHALDON S, et al: Transcription, not synthesis, of interleukin-1 and tumor necrosis factor by complement. Kidney Int 37:85-93, 1990
33. DINARELLO CA: Cytokines: Agents provocateurs in hemodialysis Kidney Int 41:683-694, 1992
34. HART PH, COOPER RL, FINLAY-JONES JJ: IL-4 suppresses IL-1 beta, TNF-alpha and PGE2 production by human peritoneal macrophages. Immunology 72:344-349, 1991
35. PORTEU F, NATHAN C: Shedding of tumor necrosis factor receptors by activated human neutrophils. J Exp Med 172:599-607, 1990
36. SPINAS GA, KELLER U, BROCKHAUS M: Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia. J Clin Invest 90:533-536, 1992
37. DINARELLO CA: Proinflammatory cytokines. Chest 118:503-508, 2000
38. PARRILLO JE, PARKER MM, NATANSON C, et al: Septic shock in humans, advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Int Med 113:227-240, 1990
39. PINSKY MR, VINCENT JL, DEVIERE J, et al: Serum cytokine levels in human septic shock: Relation to mutliple-system organ dysfunction and mortality. Chest 103:565-575, 1999
40. DONNAHOO KK, MENG XZ, AYALA A, et al: Early kidney TNF-α expression mediates neutrophil infiltration and injury after renal ischemia-reperfusion. Am J Physiol (Regul Integr Comp Physiol) 277:R922-R929, 1999
41. KELLY KJ, MEEHAN SM, COLVIN RB, et al: Protection from toxicant-mediated renal injury in the rat with anti-CD54 antibody. Kidney Int 12:922-931, 1999
42. KELLY KJ, WILLIAMS WW JR., COLVIN RB, et al: Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury. PNAS USA 91:812-816, 1994
43. RABB H, MENDIOLA CC, SABA SR, et al: Antibodies to ICAM-1 protect kidneys in severe ischemic reperfusion injury. Biochem Biophys Res Commun 211:67-73, 1995
44. SFEIR T, SAHA DC, ASTIZ M, RACKOW EC: Role of interleukin-10 in monocyte hyporesponsiveness associated with septic shock. Crit Care Med 29:129-133, 2001
45. BONE RC, GRODZIN CJ, BALK RA: Sepsis: A new hypothesis for pathogenesis of the disease process. Chest 112:235-243, 1997
46. BEUTLER B, GRAU GE: Tumor necrosis factor in the pathogenesis of infectious disease. Crit Care Med 21:S423-S435, 1993
47. LEROUX-ROELS G, OFFNER F: Tumor necrosis factor in sepsis. J Am Med Assoc 263:1494-1495, 1989
48. CALANDRA T, BAUMGARTNER JD, GRAU GE, et al: Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. Swiss-Dutch J5 Immunoglobulin Study Group. J Infect Dis 161:982-987, 1990
49. VAN DISSEL JT, VAN LANGEVELD P, WESTENDORP RGJ, et al: Antiinflammatory cytokine profile and mortality in febrile patients. Lancet 351:950-953, 1998
50. DOCKE WD, RANDOW F, SYRBE U, et al: Monocyte deactivation in septic patients: Restoration by IFN-γ treatment. Nat Med 3:678-681, 1997
51. FLACH R, MAJETSCHAK M, HEUKAMP T, et al: Relation of ex vivo stimulated blood cytokine synthesis to post-traumatic sepsis. Cytokine 11:173-178, 1999
52. MARIE C, MURET J, FITTING C, et al: Reduced ex vivo interleukin-8 production by neutrophils in septic and nonseptic systemic inflammatory response syndrome. Blood 91:3439-3446, 1998
53. JABER BL, CENDOROGLO M, BALAKRISHNAN VS, et al: Impact of dialyzer membrane selection on cellular responses in acute renal failure: A crossover study. Kidney Int 57:2107-2116, 2000
54. LONNEMANN G, BECHSTEIN M, LINNENWEBER S, et al: Tumor necrosis factor-alpha during continuous high-flux hemodialysis in sepsis with acute renal failure. Kidney Int 72(Suppl):S84-S87, 1999
55. MURAMATSU Y, TSUJIE M, KOHDA Y, et al: Early detection of cysteine rich protein 61 (CYR61, CCN1) in urine following renal ischemic reperfusion injury. Kidney Int 62:1601-1610, 2002
56. MELNIKOV VY, FAUBEL S, SIEGMUND B, et al: Neutrophil-independent mechanisms of caspase-1- and IL-18-mediated ischemic acute tubular necrosis in mice. J Clin Invest 110:1083-1091, 2002
57. HAN WK, BAILLY V, ABICHANDANI R, et al: Kidney injury molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury. Kidney Int 62:237-244, 2002